| SRHR | XLRE | SRHR / XLRE | |
| Gain YTD | -1.649 | 2.727 | -60% |
| Net Assets | 48.3M | 7.46B | 1% |
| Total Expense Ratio | 0.75 | 0.08 | 938% |
| Turnover | 44.00 | 5.00 | 880% |
| Yield | 6.97 | 3.40 | 205% |
| Fund Existence | 2 years | 10 years | - |
| SRHR | XLRE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | N/A |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 66% | 2 days ago 81% |
| Advances ODDS (%) | about 1 month ago 71% | 20 days ago 87% |
| Declines ODDS (%) | N/A | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 87% | N/A |
| Aroon ODDS (%) | 2 days ago 58% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USOI | 49.87 | 0.61 | +1.23% |
| UBS ETRACS Crude Oil Shares Cov Cll ETN | |||
| THNR | 25.22 | 0.23 | +0.94% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| LCLG | 60.58 | N/A | N/A |
| Logan Capital Broad Innovative Gr ETF | |||
| LAPR | 25.16 | N/A | N/A |
| Innovator Premium Inc 15 Bffr ETF - Aprl | |||
| IPAC | 72.65 | -1.22 | -1.65% |
| iShares Core MSCI Pacific ETF | |||
A.I.dvisor indicates that over the last year, SRHR has been loosely correlated with EQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SRHR jumps, then EQR could also see price increases.
| Ticker / NAME | Correlation To SRHR | 1D Price Change % | ||
|---|---|---|---|---|
| SRHR | 100% | -0.81% | ||
| EQR - SRHR | 43% Loosely correlated | -0.41% | ||
| NXRT - SRHR | 42% Loosely correlated | -0.55% | ||
| FR - SRHR | 41% Loosely correlated | -1.52% | ||
| AVB - SRHR | 41% Loosely correlated | -0.25% | ||
| EGP - SRHR | 40% Loosely correlated | -1.52% | ||
More | ||||